149 related articles for article (PubMed ID: 22850243)
1. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies.
Wallukat G; Haberland A; Berg S; Schulz A; Freyse EJ; Dahmen C; Kage A; Dandel M; Vetter R; Salzsieder E; Kreutz R; Schimke I
Circ J; 2012; 76(10):2449-55. PubMed ID: 22850243
[TBL] [Abstract][Full Text] [Related]
2. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.
Wallukat G; Müller J; Haberland A; Berg S; Schulz A; Freyse EJ; Vetter R; Salzsieder E; Kreutz R; Schimke I
Atherosclerosis; 2016 Jan; 244():44-7. PubMed ID: 26584137
[TBL] [Abstract][Full Text] [Related]
3. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats.
Haberland A; Wallukat G; Berg S; Schulz AM; Freyse EJ; Vetter R; Salzsieder E; Müller J; Kreutz R; Schimke I
Mol Cell Biochem; 2014 Aug; 393(1-2):177-80. PubMed ID: 24744110
[TBL] [Abstract][Full Text] [Related]
5. Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.
Haberland A; Wallukat G; Schimke I
Trends Cardiovasc Med; 2011 Aug; 21(6):177-82. PubMed ID: 22814426
[TBL] [Abstract][Full Text] [Related]
6. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
[TBL] [Abstract][Full Text] [Related]
7. Aptamer BC 007 - A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors.
Haberland A; Holtzhauer M; Schlichtiger A; Bartel S; Schimke I; Müller J; Dandel M; Luppa PB; Wallukat G
Eur J Pharmacol; 2016 Oct; 789():37-45. PubMed ID: 27375076
[TBL] [Abstract][Full Text] [Related]
8. M
Deng J; Guo Y; Zhang G; Zhang L; Kem D; Yu X; Jiang H; Li H
Exp Physiol; 2021 Apr; 106(4):882-890. PubMed ID: 33550676
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathy - An approach to the autoimmune background.
Becker NP; Müller J; Göttel P; Wallukat G; Schimke I
Autoimmun Rev; 2017 Mar; 16(3):269-286. PubMed ID: 28163240
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
Dandel M; Wallukat G; Englert A; Hetzer R
Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function.
Michelucci A; D'Elios MM; Sticchi E; Pieragnoli P; Ricciardi G; Fatini C; Benagiano M; Niccolai E; Grassi A; Attanà P; Nesti M; Grifoni G; Padeletti L; Abbate R; Prisco D
Pacing Clin Electrophysiol; 2016 Jan; 39(1):65-72. PubMed ID: 26411359
[TBL] [Abstract][Full Text] [Related]
12. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
Dandel M; Wallukat G; Potapov E; Hetzer R
Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
[TBL] [Abstract][Full Text] [Related]
13. Pro-arrhythmic action of autoantibodies against the second extracellular loop of β1-adrenoceptor and its underlying molecular mechanisms.
Zuo L; Du Y; Ma J; Wang K; Zhao Y; Bai F; Wu B; Ma X; Liu H
Int J Cardiol; 2015 Nov; 198():251-8. PubMed ID: 26241168
[TBL] [Abstract][Full Text] [Related]
14. The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors.
Liu J; Wang Y; Chen M; Zhao W; Wang X; Wang H; Zhang Z; Zhang J; Xu L; Chen J; Yang X; Zhang L
PLoS One; 2014; 9(1):e86770. PubMed ID: 24466231
[TBL] [Abstract][Full Text] [Related]
15. The relationship between β
Duan X; Liu R; Luo XL; Gao XJ; Hu FH; Guo C; Wang J; Hu XY; Chun YS; Yuan JS; Cui JG; Yang WX; Qiao SB
Exp Physiol; 2020 Mar; 105(3):522-530. PubMed ID: 31808213
[TBL] [Abstract][Full Text] [Related]
16. Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential.
Wang L; Lu K; Hao H; Li X; Wang J; Wang K; Wang J; Yan Z; Zhang S; Du Y; Liu H
PLoS One; 2013; 8(11):e81296. PubMed ID: 24278413
[TBL] [Abstract][Full Text] [Related]
17. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.
Wallukat G; Schimke I
Semin Immunopathol; 2014 May; 36(3):351-63. PubMed ID: 24777744
[TBL] [Abstract][Full Text] [Related]
18. Functional autoantibody diseases: Basics and treatment related to cardiomyopathies.
Becker NP; Goettel P; Mueller J; Wallukat G; Schimke I
Front Biosci (Landmark Ed); 2019 Jan; 24(1):48-95. PubMed ID: 30468647
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
Wallukat G; Jandrig B; Kunze R; Wendler JJ; Müller J; Schostak M; Schimke I
Prostate; 2017 Apr; 77(5):458-465. PubMed ID: 27882567
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
